Literature DB >> 8234450

Benefits and risks of psychotropic medication in the eyes of the general public: results of a survey in the Federal Republic of Germany.

M C Angermeyer1, R Däumer, H Matschinger.   

Abstract

In 1990, a survey of the population of the FRG, including the new states, was carried out to investigate the attitude of the general public toward psychotropic drugs. This showed that they are regarded with fare more suspicion than trust. Their use in the treatment of mental disorder was rejected twice as often as it was recommended. Those questioned submitted three main arguments against the use of psychotropics: (1) they can cause unwanted effects, in particular dependency; (2) their action is restricted, i.e., they only treat the symptoms and not the cause of the illness; (3) they are ineffective, having either no effect or effects of doubtful or temporary nature. The use of psychotropic agents was recommended, if at all, for the purpose of sedating the patients, providing relief from their problems, and lessening their symptoms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8234450     DOI: 10.1055/s-2007-1014354

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  13 in total

1.  The public debate on psychotropic medication and changes in attitudes 1990-2011.

Authors:  Matthias C Angermeyer; Sandra Van der Auwera; Herbert Matschinger; Mauro G Carta; Sebastian E Baumeister; Georg Schomerus
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-28       Impact factor: 5.270

2.  Mental Health Literacy: Past, Present, and Future.

Authors:  Stan Kutcher; Yifeng Wei; Connie Coniglio
Journal:  Can J Psychiatry       Date:  2016-03       Impact factor: 4.356

3.  Belief systems of the general public concerning the appropriate treatments for mental disorders.

Authors:  A F Jorm; A E Korten; B Rodgers; P Pollitt; P A Jacomb; H Christensen; Z Jiao
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-11       Impact factor: 4.328

Review 4.  The public stigma of mental illness: what do we think; what do we know; what can we prove?

Authors:  Bernice A Pescosolido
Journal:  J Health Soc Behav       Date:  2013-01-16

5.  Evaluation of a brief anti-stigma campaign in Cambridge: do short-term campaigns work?

Authors:  Sara Evans-Lacko; Jillian London; Kirsty Little; Claire Henderson; Graham Thornicroft
Journal:  BMC Public Health       Date:  2010-06-14       Impact factor: 3.295

6.  Attitudes towards drugs--a survey in the general population.

Authors:  D Isacson; K Bingefors
Journal:  Pharm World Sci       Date:  2002-06

7.  Attitudes toward psychiatric drug treatment: the experience of being treated.

Authors:  Carlos De Las Cuevas; Emilio J Sanz
Journal:  Eur J Clin Pharmacol       Date:  2007-08-16       Impact factor: 2.953

8.  Attitudes to antipsychotic drugs and their side effects: a comparison between general practitioners and the general population.

Authors:  Josef Helbling; Vladeta Ajdacic-Gross; Christoph Lauber; Ruth Weyermann; Tom Burns; Wulf Rössler
Journal:  BMC Psychiatry       Date:  2006-10-18       Impact factor: 3.630

9.  What makes people decide who to turn to when faced with a mental health problem? Results from a French survey.

Authors:  Viviane Kovess-Masféty; Delphine Saragoussi; Christine Sevilla-Dedieu; Fabien Gilbert; Agnieszka Suchocka; Nathalie Arveiller; Isabelle Gasquet; Nadia Younes; Marie-Christine Hardy-Bayle
Journal:  BMC Public Health       Date:  2007-07-31       Impact factor: 3.295

10.  Public beliefs about treatment and outcome of mental disorders: a comparison of Australia and Japan.

Authors:  Anthony F Jorm; Yoshibumi Nakane; Helen Christensen; Kumiko Yoshioka; Kathleen M Griffiths; Yuji Wata
Journal:  BMC Med       Date:  2005-07-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.